A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology

The current inability of clinical criteria to accurately identify the “at-risk group” for Amyotrophic Lateral Sclerosis (ALS) development as well as its unknown etiology are fueling the interest in biomarkers aimed at completing clinical approaches for the diagnosis. The Glial cell line-derived neur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Stanga, Serena, Brambilla, Liliana, Tasiaux, Bernadette, Dang, Anh H., Ivanoiu, Adrian, Octave, Jean-Noël, Rossi, Daniela, van Pesch, Vincent, Kienlen-Campard, Pascal
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5988896/
https://ncbi.nlm.nih.gov/pubmed/29899726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2018.00384
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados